Literature DB >> 14573332

Influence of low high-density lipoprotein cholesterol on left ventricular hypertrophy and diastolic function in essential hypertension.

Takeshi Horio1, Junko Miyazato, Kei Kamide, Shin Takiuchi, Yuhei Kawano.   

Abstract

BACKGROUND: Left ventricular (LV) hypertrophy and LV diastolic dysfunction, which are common cardiac changes in hypertensive patients, are modified by several nonhemodynamic (eg, genetic, neurohumoral, and metabolic) factors. However, the influence of serum lipids on these LV changes has not been sufficiently studied. Although low high-density lipoprotein (HDL) cholesterol is well known to be a major risk factor for coronary heart disease, it is unclear whether HDL cholesterol plays a role in hypertensive heart disease.
METHODS: In 274 patients with treated essential hypertension, two-dimensional and Doppler echocardiography were performed, and LV mass, ratio of peak velocity of atrial filling to early diastolic filling (A to E ratio [A/E]), and deceleration time of the E-wave were evaluated. The relationship of dyslipidemia, especially low HDL cholesterol, to LV hypertrophy and diastolic function was investigated in these patients.
RESULTS: In a univariate regression analysis, HDL cholesterol was inversely associated with LV mass, A/E, and deceleration time. The association of HDL cholesterol with LV diastolic function was observed in both men and women. Its association with LV mass was gender-dependent, being significant only in women. Triglycerides were weakly correlated with LV mass and A/E, but total and low-density lipoprotein cholesterol had no correlations with these indices. In a multiple regression analysis, only low HDL cholesterol among several lipid levels was an independent predictor of both LV mass and LV diastolic dysfunction.
CONCLUSIONS: Our findings suggest that low HDL cholesterol may unfavorably modify LV structure and diastolic function in patients with treated essential hypertension.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14573332     DOI: 10.1016/s0895-7061(03)01015-x

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  28 in total

Review 1.  Cardiac remodeling at the population level--risk factors, screening, and outcomes.

Authors:  Ola Gjesdal; David A Bluemke; Joao A Lima
Journal:  Nat Rev Cardiol       Date:  2011-10-25       Impact factor: 32.419

2.  Determinants of concentric left ventricular hypertrophy in patients with resistant hypertension: RESIST-POL study.

Authors:  Piotr Dobrowolski; Aleksander Prejbisz; Anna Klisiewicz; Elżbieta Florczak; Justyna Rybicka; Andrzej Januszewicz; Piotr Hoffman
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

3.  Cross-sectional relations of lipid concentrations to left ventricular structural attributes.

Authors:  Raghava S Velagaleti; Michael J Pencina; Ramachandran S Vasan; Emelia J Benjamin; Joseph M Massaro; Karol Pencina; Daniel Levy
Journal:  Am J Cardiol       Date:  2010-03-11       Impact factor: 2.778

4.  Racial differences in incident heart failure among young adults.

Authors:  Kirsten Bibbins-Domingo; Mark J Pletcher; Feng Lin; Eric Vittinghoff; Julius M Gardin; Alexander Arynchyn; Cora E Lewis; O Dale Williams; Stephen B Hulley
Journal:  N Engl J Med       Date:  2009-03-19       Impact factor: 91.245

5.  Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study.

Authors:  Raghava S Velagaleti; Joseph Massaro; Ramachandran S Vasan; Sander J Robins; William B Kannel; Daniel Levy
Journal:  Circulation       Date:  2009-11-23       Impact factor: 29.690

6.  Preclinical left ventricular diastolic dysfunction in metabolic syndrome.

Authors:  Nir Ayalon; Deepa M Gopal; Deirdre M Mooney; Juliana S Simonetti; Jason R Grossman; Aeshita Dwivedi; Courtney Donohue; Alejandro J Perez; Jill Downing; Noyan Gokce; Edward J Miller; Chang-Seng Liang; Caroline M Apovian; Wilson S Colucci; Jennifer E Ho
Journal:  Am J Cardiol       Date:  2014-07-01       Impact factor: 2.778

7.  Impact of duration and dosage of statin treatment and epicardial fat thickness on the recurrence of atrial fibrillation after electrical cardioversion.

Authors:  Kyoung-Im Cho; Bong-Joon Kim; Tae-Joon Cha; Jung-Ho Heo; Hyun-Su Kim; Jae-Woo Lee
Journal:  Heart Vessels       Date:  2014-04-02       Impact factor: 2.037

8.  Influence of low high-density lipoprotein cholesterol on arterial stiffening and left ventricular diastolic dysfunction in essential hypertension.

Authors:  Dong-Mei Miao; Ping Ye; Wen-Kai Xiao; Peng Gao; Jin-Yao Zhang; Hong-Mei Wu
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-07-14       Impact factor: 3.738

9.  Single- or double-blind treatment With Balsamodendron mukul and nifedipine in hypertensive patients.

Authors:  Jayabal Panneerselvam; Ganapathy Sambandam; Namasivayam Nalini
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-06       Impact factor: 3.738

10.  Cardiac, Macro-, and Micro-Circulatory Abnormalities in Association With Individual Metabolic Syndrome Component: The Northern Shanghai Study.

Authors:  Fang Zhao; Rong Yang; Rusitanmujiang Maimaitiaili; Jiamin Tang; Song Zhao; Jing Xiong; Jiadela Teliewubai; Chen Chi; Jacques Blacher; Jue Li; Yawei Xu; Yan Jiang; Yi Zhang; Weiming Li
Journal:  Front Cardiovasc Med       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.